August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
View our poster on Characteristics and Disease Management in a Large Real World Lupus Nephritis Cohort in the U.S. Click to view more!
New Project Puts Standardized Outcomes Measures for Depression into Real-World Use, from Registries to the Clinic OM1 partners with AHRQ, ABFM, APA and others to implement BOSTON, July 17, 2019 —OM1, a leading health outcomes and technology company, today announced it is has been awarded the CAPSTONE – Outcome Measure Harmonization and Data Infrastructure for[…]
Read the decision memo: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=292
November 15, 2018 —OM1, a leading health outcomes and technology company, today announced the publication of new harmonized outcome measures for atrial fibrillation (AF) in HeartRhythm. OM1’s Richard Gliklich and Michelle Leavy collaborated on the development of the measures and co-authored the publication. The work was funded by the Agency for Healthcare Research and Quality (AHRQ) through[…]
